AR-15512

· Aerie Pharmaceuticals

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AR-15512, covering 2025-07-23 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease [Phase 3]